Lamivudine triphosphate

Overview

Lamivudine triphosphate (3TCTP) is a phosphorylated Lamivudine ( HY-B0250 ) (a nucleoside analogue). Lamivudine triphosphate inhibits the reverse transcriptase of HIV or HBV viruses to block viral replication by chain termination. Lamivudine triphosphate is also an inhibitor of the RdRp activity of the NS5B subunit of the HCV . Lamivudine triphosphate can be incorporated into the nascent RNA by the SARS-CoV-2 RdRp, thus halting mutations in the nascent SARS-CoV-2 RNA.

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Others | Products > Research Areas > Infection | Products > Signaling Pathways > Reverse Transcriptase | Products > Signaling Pathways > HCV | Products > Signaling Pathways > HBV | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-131603
• CAS No.: 143188-53-8
• Molecular Formula: C8H14N3O12P3S
• Molecular Weight: 469.20
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source